Heartbeat Experts Updates on Company Sales Growth

Heartbeat Experts, a company focusing on stakeholder management solutions for the life sciences industry, announced 44 percent sales growth during first three quarters of 2013.

Heartbeat Expert's market access division propelled this growth reporting a sales increase of 600 percent during the same period under comparison. The company also reported adding fifteen new life sciences firms to their client list during that period.

According to the company, to further support continued market access growth Heartbeat Experts launched a software module for managing and mapping market access opinion leaders, key stakeholders and their networks. The new module allows users to visualize social networks through dynamic maps that uncover national, regional and local decision makers and influencers. The module has been successfully rolled out to clients in Latin America, the US and Canada, greater Europe, and Asia Pacific.

Explaining the growth, Jonah Meyers, CEO of Heartbeat Experts, said, "Today, government payers, insurers and Health Technology Assessment (HTA) groups are exerting greater influence over pharmaceutical pricing, reimbursement, and product approval. In response, our clients are revamping the way they approach market access. They're planning for market access far earlier and more aggressively by analyzing and mapping decision making bodies, networks, and key stakeholders on a country by country basis and even region by region."

Larry Cohen, President of Heartbeat Experts, added, "Our clients cannot successfully access their key markets and achieve their pricing and reimbursement goals unless they target and collaborate with the right Key Opinion Leaders (KOLs), HEOR experts and patient advocates in each country they want to launch. We are seeing in China, Latin America, throughout Europe that our software and maps give our clients the networks they need to execute their market access strategy."

Heartbeat Experts is a stakeholder management solution provider serving 20 of the top 20 pharmaceutical companies and 18 of the top 20 medical device companies.

((Comments on this story may be sent to [email protected]))